Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Cancer Research
|
January 1, 2016
Anticancer Effects of Mesothelin-Targeted Immunotoxin Therapy Are Regulated by Tyrosine Kinase DDR1
Fatima Ali-Rahmani, David J FitzGerald, Scott Martin, et al.
Oncotarget
|
September 17, 2016
Blocking downstream signaling pathways in the context of HDAC inhibition promotes apoptosis preferentially in cells harboring mutant Ras
Julian C Bahr, Robert W Robey, Victoria Luchenko, et al.
Molecular Cancer Therapeutics
|
August 10, 2019
Target Deconvolution of a Multikinase Inhibitor with Antimetastatic Properties Identifies TAOK3 as a Key Contributor to a Cancer Stem Cell-Like Phenotype
Yansong Bian, Yaroslav Teper, Lesley A Mathews Griner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 14, 2018
FDA Approval: Ribociclib for the Treatment of Postmenopausal Women with Hormone Receptor-Positive, HER2-Negative Advanced or Metastatic Breast Cancer
Anand Shah, Erik Bloomquist, Shenghui Tang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 9, 2022
FDA Approval Summary: Belumosudil for Adult and Pediatric Patients 12 Years and Older with Chronic GvHD after Two or More Prior Lines of Systemic Therapy
Donna Przepiorka, Robert Q Le, Alexei Ionan, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 29, 2013
Genomic and functional characterizations of phosphodiesterase subtype 4D in human cancers
De-Chen Lin, Liang Xu, Ling-Wen Ding, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 14, 2018
FDA Approval Summary: (Daunorubicin and Cytarabine) Liposome for Injection for the Treatment of Adults with High-Risk Acute Myeloid Leukemia
Aviva C Krauss, Xin Gao, Liang Li, et al.
Journal of Pharmaceutical Sciences
|
January 13, 2023
FDA/M-CERSI Co-Processed API Workshop Proceedings
Luke Schenck, Paresma Patel, Ramesh Sood, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 22, 2023
FDA Approval Summary: Mirvetuximab Soravtansine-Gynx for FRα-Positive, Platinum-Resistant Ovarian Cancer
Asma Dilawari, Mirat Shah, Gwynn Ison, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 29, 2014
High-throughput combinatorial screening identifies drugs that cooperate with ibrutinib to kill activated B-cell-like diffuse large B-cell lymphoma cells
Lesley A Mathews Griner, Rajarshi Guha, Paul Shinn, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Cancer Research
|
January 1, 2016
Anticancer Effects of Mesothelin-Targeted Immunotoxin Therapy Are Regulated by Tyrosine Kinase DDR1
Fatima Ali-Rahmani, David J FitzGerald, Scott Martin, et al.
Oncotarget
|
September 17, 2016
Blocking downstream signaling pathways in the context of HDAC inhibition promotes apoptosis preferentially in cells harboring mutant Ras
Julian C Bahr, Robert W Robey, Victoria Luchenko, et al.
Molecular Cancer Therapeutics
|
August 10, 2019
Target Deconvolution of a Multikinase Inhibitor with Antimetastatic Properties Identifies TAOK3 as a Key Contributor to a Cancer Stem Cell-Like Phenotype
Yansong Bian, Yaroslav Teper, Lesley A Mathews Griner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 14, 2018
FDA Approval: Ribociclib for the Treatment of Postmenopausal Women with Hormone Receptor-Positive, HER2-Negative Advanced or Metastatic Breast Cancer
Anand Shah, Erik Bloomquist, Shenghui Tang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 9, 2022
FDA Approval Summary: Belumosudil for Adult and Pediatric Patients 12 Years and Older with Chronic GvHD after Two or More Prior Lines of Systemic Therapy
Donna Przepiorka, Robert Q Le, Alexei Ionan, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 29, 2013
Genomic and functional characterizations of phosphodiesterase subtype 4D in human cancers
De-Chen Lin, Liang Xu, Ling-Wen Ding, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 14, 2018
FDA Approval Summary: (Daunorubicin and Cytarabine) Liposome for Injection for the Treatment of Adults with High-Risk Acute Myeloid Leukemia
Aviva C Krauss, Xin Gao, Liang Li, et al.
Journal of Pharmaceutical Sciences
|
January 13, 2023
FDA/M-CERSI Co-Processed API Workshop Proceedings
Luke Schenck, Paresma Patel, Ramesh Sood, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 22, 2023
FDA Approval Summary: Mirvetuximab Soravtansine-Gynx for FRα-Positive, Platinum-Resistant Ovarian Cancer
Asma Dilawari, Mirat Shah, Gwynn Ison, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 29, 2014
High-throughput combinatorial screening identifies drugs that cooperate with ibrutinib to kill activated B-cell-like diffuse large B-cell lymphoma cells
Lesley A Mathews Griner, Rajarshi Guha, Paul Shinn, et al.
Page
of 1